Skip to content
Sunday, November 15, 2026
Gamora Systems

The Global Health Body Issues Concern Over Critical Shortage of Obesity Jabs

Under a tenth of patients that would benefit from weight-loss injections like Wegovy have access to them, states the WHO as it releases its initial advice on the medications.

Given in excess of 1,000,000,000 people worldwide now classified as obese, it is advocating for increased and just access to this class of drugs.

Based on projections, more than two billion will be living with obesity by 2030 unless action is taken.

"Our latest guidelines recognises that obesity is a chronic disease that can be managed with thorough and lifelong support," stated WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, limited production capacity, and logistical bottlenecks are major hurdles to universal access to the treatments that can assist patients in reducing substantial body mass, explains the organization.

GLP-1 Therapy Supply Crisis

Even under the current most favorable outlook, the production of such drugs could only cover approximately 100 million people – under 10% of the global need, as stated by the WHO.

The recommendation urges governments and firms to expand access, through strategies like licensing agreements.

The intellectual property rights on semaglutide – the main component of the drug Wegovy – is due to expire in a number of nations in 2026.

How Weight-Loss Drugs Operate

These medications mimick a body's own hormone to slow digestion, reduce hunger and enhance feelings of fullness so individuals consume fewer calories.

Individuals typically begin shedding pounds within a few weeks of starting on the weekly injections.

Evidence suggests users may see weight return after a year of stopping the drug, as their typical hunger return.

Being carrying excess weight increases your risk for experiencing diseases, including diabetes, cardiovascular issues, brain attack, and specific malignancies.

Excess weight affects individuals in all nations and was associated with over three and a half million deaths worldwide in 2024, as per the health agency.

BM
Written by

Brent Martinez

A tech strategist with over a decade of experience in digital transformation and cloud computing solutions across European markets.

Gamora Systems

Type to search articles.